Diabetes 56:3-7, 2007 DOI: 10.2337/db06-1165 © 2007 by the American Diabetes Association
Islet-Derived Fibroblast-Like Cells Are Not Derived via Epithelial-Mesenchymal Transition From Pdx-1 or Insulin-Positive CellsFrom the Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota Address correspondence and reprint requests to Catherine M. Verfaillie Stem Cell Institute, University of Minnesota, McGuire Translational Research Facility, 2001 6th St. SE, mail code 2873, Minneapolis, MN 55455. E-mail: verfa001{at}umn.edu
Abbreviations:
BM-MSC, bone marrow mesenchymal stem cell; CAAGS, chicken ß-actin promoter/cytomegalovirus enhancer; EMT, epithelial-mesenchymal transition; FACS, fluorescence-activated cell sorter; GFP, green fluorescent protein; MSC, mesenchymal stem cell; qPCR, quantitative PCR
As recent studies suggest that newly formed pancreatic ß-cells are a result of self-duplication rather than stem cell differentiation, in vitro expansion of ß-cells presents a potential mechanism by which to increase available donor tissue for cell-based diabetes therapies. Although most studies have found that ß-cells are resilient to substantial in vitro expansion, recent studies have suggested that it is possible to expand these cells through a process referred to as epithelial-mesenchymal transition (EMT). To further substantiate such an expansion mechanism, we used recombination-based genetic lineage tracing to determine the origin of proliferating fibroblast-like cells from cultured pancreatic islets in vitro. We demonstrate, using two culture methods, that EMT does not underlie the appearance of fibroblast-like cells in mouse islet cultures but that fibroblast-like cells appear to represent mesenchymal stem cell (MSC)-like cells akin to MSCs isolated from bone marrow.
This article has been cited by other articles:
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||